Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study

Published:2005-08-10 Issue:9 Volume:21 Page:1389-1399
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Ganse Eric Van¹,Laforest Laurent¹,Alemao Evo²,Davies Glenn³,Gutkin Stephen⁴,Yin Don²

Affiliation:

1. Pharmacoepidemiology EA 3091 Centre Hospitalier Lyon-Sud, France

2. Outcomes Research, Merck and Co. Inc., Whitehouse Station, NJ, USA

3. Health Economic Statistics, Merck Research Laboratories, Blue Bell, PA, USA

4. Rete Biomedical Communications Corp., Ridgewood, NJ, USA

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/030079905X59139

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incremental progress but still far from good enough: real-world LDL-cholesterol insights from the SANTORINI 1-year follow-up study;European Journal of Preventive Cardiology;2024-06-24

2. Cardiovascular risk management: the success of target level achievement in high- and very high-risk patients in Hungary;BMC Primary Care;2022-11-29

3. Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study;Frontiers in Medicine;2022-05-19

4. Inclisiran in lipid management: A Literature overview and future perspectives;Biomedicine & Pharmacotherapy;2021-11

5. Efficacy and Safety of Ezetimibe in Combination with Atorvastatin for Acute Coronary Syndrome Patients Accompanied with Type 2 Diabetes: A Single-Center, Non-randomized Cohort Study;Chemical and Pharmaceutical Bulletin;2019-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3